Cagrilintide (AM833) is a modified amylin analog, developed for obesity management. By binding to both the amylin and calcitonin receptors, results in decreased food intake and significant weight reduction. Its mechanism Improves its effectiveness compared to traditional amylin treatments. In clinical trials, cagrilintide, alone or with semaglutide, has demonstrated notable weight loss benefits and It also offers promise for treating type 2 diabetes by improving blood glucose control and HbA1c levels.
Larsen, A.T., Mohamed, K.E., Sonne, N., Bredtoft, E., Andersen, F., Karsdal, M.A. and Henriksen, K. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomedicine & Pharmacotherapy. Elsevier.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Cagrilintide Acetate by Dragon Pharma, consult with your doctor or healthcare professional.
Larsen, A.T., Mohamed, K.E., Sonne, N., Bredtoft, E., Andersen, F., Karsdal, M.A. and Henriksen, K. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomedicine & Pharmacotherapy. Elsevier.
Larsen, A.T., Mohamed, K.E., Sonne, N., Bredtoft, E., Andersen, F., Karsdal, M.A. and Henriksen, K. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomedicine & Pharmacotherapy. Elsevier.
Larsen, A.T., Mohamed, K.E., Sonne, N., Bredtoft, E., Andersen, F., Karsdal, M.A. and Henriksen, K. (2022). Does receptor balance matter? – Comparing the efficacies of the dual amylin and calcitonin receptor agonists cagrilintide and KBP-336 on metabolic parameters in preclinical models. Biomedicine & Pharmacotherapy. Elsevier.
Home
